Arnaud Ajdler, Director at Recro Pharma, Inc. (REPH), bought 40,000 shares at $9.00 ($360K) on 2019-05-17, disclosed to the SEC on 2019-05-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HIL | BUY | 2018-12-14 | $455K | — | Filing → |
| HIL | BUY | 2018-11-21 | $1.0M | — | Filing → |
| SRT | SELL | 2017-06-01 | $2.2M | — | Filing → |